Results 241 to 250 of about 4,755,015 (314)
Rasch Analysis and Interval-Level Scaling of the Positive and Negative Affect Schedule (PANAS) Across Cultures. [PDF]
Adu P.
europepmc +1 more source
Interpreting the effects of DNA polymerase variants at the structural level
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi +7 more
wiley +1 more source
Measuring eHealth Literacy in the European Economic Area, Switzerland, and the United Kingdom: Scoping Review. [PDF]
Weist JV +3 more
europepmc +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
OPTIMAL SAMPLING STRATEGIES FOR BAND-PASS MEASUREMENT SIGNALS [PDF]
SCHIANO LO MORIELLO, ROSARIO +3 more
core
Multi-Target Radar Speed Meter Failure Mechanism Research. [PDF]
Luo L +6 more
europepmc +1 more source
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy +10 more
wiley +1 more source
Cosmin reporting guideline for studies on measurement properties of patient-reported outcome measures and its explanation and elaboration document: translation into Brazilian Portuguese. [PDF]
de Arruda GT +4 more
europepmc +1 more source
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source

